SCHEMBL21591961

SCHEMBL21591961

CN(C/C=C/C#CC(C)(C)C)c1cccc2ccccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.65
SQLE Q14534 3/20 0.65
LMNA P02545 2/20 0.65
CYP2D6 P10635 2/20 0.65
SLC6A2 P23975 2/20 0.65
ADRA2A P08913 1/20 0.65
NR1I2 O75469 1/20 0.36
DRD2 P14416 1/20 0.36
ADRA2C P18825 1/20 0.36
CNR1 P21554 1/20 0.36
HTR2A P28223 1/20 0.36
SLC6A4 P31645 1/20 0.36
ADRA1A P35348 1/20 0.36
OPRK1 P41145 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KCNH2 Q12809 1/20 0.36
EBP Q15125 1/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30408182 0.99 SIGMAR1 (0.64) SIGMAR1SQLELMNACYP2D6SLC6A2
Hydrochloric Acid SCHEMBL31374682 0.99 SIGMAR1 (0.64) SIGMAR1SQLELMNACYP2D6SLC6A2
Terbinafine SCHEMBL31374681 0.79 CYP2D6 (1.00) SIGMAR1SQLELMNACYP2D6SLC6A2
Terbinafine SCHEMBL37843 0.79 CYP2D6 (1.00) SIGMAR1SQLELMNACYP2D6SLC6A2
Terbinafine SCHEMBL5279646 0.79 CYP2D6 (1.00) SIGMAR1SQLELMNACYP2D6SLC6A2
Terbinafine SCHEMBL36794 0.79 CYP2D6 (1.00) SIGMAR1SQLELMNACYP2D6SLC6A2
Terbinafine SCHEMBL2042785 0.79 CYP2D6 (1.00) SIGMAR1SQLELMNACYP2D6SLC6A2
Terbinafine SCHEMBL2028187 0.79 CYP2D6 (1.00) SIGMAR1SQLELMNACYP2D6SLC6A2
Terbinafine SCHEMBL29627458 0.79 CYP2D6 (1.00) SIGMAR1SQLELMNACYP2D6SLC6A2
Terbinafine SCHEMBL29353314 0.79 CYP2D6 (1.00) SIGMAR1SQLELMNACYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3581566-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS CELLIX BIO PRIVATE LIMITED (IN) 2019-12-18 EP disclosed